ClinOne Medical-Grade Remote Monitoring Coupled with the...

ClinOne Medical-Grade Remote Monitoring Coupled with the BioIntelliSense FDA-Cleared BioSticker Device to Help Remote Patient Monitoring

By Pharma Tech Outlook | Tuesday, March 31, 2020

An announcement has been addressed by ClinOne about its strategic collaboration with BioIntelliSense to continue a combined health monitoring and clinical intelligence with the ClinOne ClinTrialConnect patient portal platform.

FREMONT, CA- The addition of an effortless trial participant experience, the FDA-cleared BioSticker single-use device, enables a 30-day continuous vital sign monitoring. The CEO Rob Bohacs states, “With BioIntelliSense, we will be able to capture a wide array of medical-grade biosensor data and offer our enterprise clients a new standard for Remote Patient Monitoring (RPM), resulting in more efficient and scalable virtual clinical trials.”

An extensive view of a patient’s health status is provided with the introduction of the BioIntelliSense Data-as-a-Service platform, and BioSticker device shuts the real-world data (RWD) gap in clinical trials. The BioSticker device allows the medical-grade remote data capture of the vital signs that are safely and wirelessly transmitted to the BioIntelliSense BioCloud and ClinOne ClinTrialConnect platform for an excellent quality resolution patient trending and reporting.  James Mault, MD, BioIntelliSense CEO, rightly states, “Continuous health monitoring is poised to redefine clinical trials through effortless patient experience and medical-grade personalized intelligence that is built for scale.”

BioIntelliSense and ClinOne make medical-grade monitoring and clinical trial experiences very simple and easy. The clinical trial sites and principal investigators are provided with an algorithmic fusion of vital sign data and physiological biosignals by the cost-effective BioSticker medical device and data services including the respiratory rate at rest, heart rate at rest, body position, skin temperature, activity level, sleep status, fall detection, and gait analysis.

“We are extremely excited about the strategic collaboration with BioIntelliSense to help move clinical trials into a new frontier with the next generation of safety and remote monitoring of patients. Through our combined capabilities, we can significantly reduce the cost of clinical trials by monitoring patients and their well-being remotely through the FDA-cleared BioSticker device,” added Rob Bohacs.

The ClinOne solution and its wide range of products were created to improve clinical trial enrollment, retention, and research site compliance. The company’s primary mission is to enable essential trial details to be at the fingertips of participating researchers and patients.

In the present day, ClinOne, which was featured as one of the Top 10 eClinical Trial Management Solution Providers– 2019 by Pharma Tech Outlook, has 3,000 active clinical trials going on in 55 countries across 43 languages relying upon its suite of technologies.

Weekly Brief

Read Also